"2024 marked a transformative year for Teva, resulting in a second consecutive year of growth, driven by our generic products and key innovative products. Medicine Pills (credit: INGIMAGE ...

Teva Pharmaceutical (NYSE:TEVA) has received regulatory clearance to market its movement disorder therapy Austedo XR as a one-pill, once-daily treatment option in four new dosing strengths in the ...

Teva's Cima drug delivery unit has developed a new gel barrier technology which means the pill can't be crushed, injected or snorted. This could help cut the deadly toll of opioid abuse in the US ...

A daily pill that helps people stop smoking is to be ... The generic from drugmaker Teva – which has been on the market in other countries for several years – was recently approved by the ...